Standard PMOS management GLP-1 therapy, hormonal regulation addresses the metabolic and ovarian components, but does not specifically restore central desire pathways
Thomas DA, Kantarjian HM, Cortes J, Faderl S, Giles F, Garcia-Manero G, Wierda W, Ferrajoli A, Ravandi-Kashani F, Verstovsek S, Andreeff M , Letvak LA, Jones D, Champlin R, OBrien S
PlexusDx's Precision Peptide Genetic Test ($99 add-on) analyzes GLP1R rs6923761 and 13 other pathway variants that influence how your nervous system responds to GLP-1 activation
Mechanisms underlying the anorexigenic effects of GLP-1 receptor agonists The anorexigenic effects of GLP-1RAs are primarily mediated by the activation of GLP-1Rs expressed in the brain
For example, you were previously using a higher-maintenance dose (such as 2.4 mg)
PlexusDx's personalized approachwhether you're taking compounded semaglutide ($189/mo), oral semaglutide ($289/mo month-to-month, or from $249/mo on the 6-month plan), compounded tirzepatide ($289/mo), or our innovative GLP-Squared formulation ($289/mo)allows providers to adjust your protocol based on your individual tolerance and genetic insights
